Physician profile
Daniel H Kim
NPI 1275542516
$82,657.77
in general payments reported to CMS, 2019-2025
19 companies · $8,834 in 2025
The $8,834 reported for 2025 was more than what 85% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $13K · 2021: $18K · 2022: $4,751 · 2023: $12K · 2024: $12K · 2025: $8,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $25K · Food and Beverage: $5,664 · Travel and Lodging: $1,742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $24,932.48 |
| Food and Beverage | $5,663.53 |
| Travel and Lodging | $1,741.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $65,060.34 | 2019-2025 | Expedium |
| Intuitive Surgical, INC. | $7,885.65 | 2021 | |
| Stryker Corporation | $3,846.18 | 2019-2025 | Everest Spinal System, Xia 3, Ozark Cervical Plate System |
| Medtronic, INC. | $1,243.73 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Strata |
| Boston Scientific Corporation | $1,235.73 | 2019-2020 | |
| Vb Spine LLC | $1,207.64 | 2025 | Xia 3, Na, Avs |
| Nevro Corp. | $897.05 | 2023-2024 | Senza, Vyrsa V1 |
| Globus Medical, INC. | $223.93 | 2025 | Senza |
| Zimvie INC. | $205.96 | 2023 | |
| Cerapedics INC. | $165.81 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic USA, INC. | $158.14 | 2019 | |
| Livanova USA, INC. | $145.55 | 2024 | Vns Therapy Symmetry Model 8103 Generator |
| Genzyme Corporation | $112.36 | 2022 | |
| Medtronic Vascular, INC. | $72.32 | 2019 | |
| Pfizer INC. | $61.60 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $53.92 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $41.99 | 2023 | Ajovy |
| Takeda Pharmaceuticals U.S.A., INC. | $24.80 | 2023 | |
| Btg International INC. | $15.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.